Galapagos NV
GLPG
#4563
Rank
ยฃ1.58 B
Marketcap
ยฃ23.70
Share price
-0.57%
Change (1 day)
11.93%
Change (1 year)

Market capitalization of Galapagos NV (GLPG)

Market cap: ยฃ1.58 Billion

As of December 2025 Galapagos NV has a market cap of ยฃ1.58 Billion. This makes Galapagos NV the world's 4563th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Galapagos NV from 2008 to 2025

End of year Market Cap

Year Marketcap Change
2025ยฃ1.58 B10.51%
2024ยฃ1.43 B-31.82%
2023ยฃ2.10 B-12.94%
2022ยฃ2.41 B-10.76%
2021ยฃ2.70 B-43.03%
2020ยฃ4.75 B-53.89%
2019ยฃ10.30 B160.55%
2018ยฃ3.95 B11.27%
2017ยฃ3.55 B47.14%
2016ยฃ2.41 B45.19%
2015ยฃ1.66 B353.78%
2014ยฃ0.36 B-3.53%
2013ยฃ0.37 B8.67%
2012ยฃ0.34 B52.36%
2011ยฃ0.22 B-16.73%
2010ยฃ0.27 B74.96%
2009ยฃ0.15 B124.65%
2008ยฃ70.11 M

End of Day market cap according to different sources

On Dec 6th, 2025 the market cap of Galapagos NV was reported to be:

ยฃ1.56 Billion
by Nasdaq info icon info icon
ยฃ1.58 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
AstraZeneca
AZN
ยฃ209.72 B 13,138.28%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
ยฃ364.92 B 22,934.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ90.68 B 5,624.04%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
ยฃ299.70 B 18,817.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
ยฃ65.88 M-95.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
ยฃ163.28 B 10,206.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ24.49 B 1,445.91%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
ยฃ73.29 B 4,526.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
ยฃ186.82 B 11,692.81%๐Ÿ‡บ๐Ÿ‡ธ USA